Type 2 Diabetic Nephropathy
5 clinical trials · Condition
◉ Watch Type 2 Diabetic Nephropathy
| Record | Firm | Date |
|---|---|---|
| Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients (NCT06606093) | Daewoong Pharmaceutical Co. LTD. | 2024-09-23 |
| Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy (NCT06182891) | The Affiliated Hospital of Xuzhou Medical University | 2021-10-30 |
| Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan (NCT03147677) | The Third Xiangya Hospital of Central South University | 2016-07-28 |
| A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy (NCT01488877) | Pfizer | 2012-01-01 |
| Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy (NCT01300273) | Shanghai Jiao Tong University School of Medicine | 2011-02-01 |
Track Type 2 Diabetic Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.